There are some skin conditions we're very familiar with: spots during adolescence, allergic rashes, sunburn. But others are ...

telangiectasia, inflammatory lesions, and ocular manifestations. Among the more recently approved treatments for rosacea — and among products and drug indications under study — “notice there ...

Patients with rosacea and skin of color are more likely to have severe disease phenotypes when compared with White patients with rosacea.

“NRS-funded studies discovered that abnormal production of cathelicidins led to inflammatory lesions in rosacea patients, as well as vascular effects such as flushing and telangiectasia,” Huff ...

Vascular rosacea causes skin discoloration in the central area of the face that may come and go. Topical treatments and lifestyle measures can help, including avoiding things that trigger a flare-up.

Encelto, the first FDA-approved treatment for MacTel, is implanted intravitreally during a surgery performed by a qualified ophthalmologist. The Food and Drug Administration (FDA) has approved ...

Revakinagene taroretcel-lwey (Encelto; Neurotech), an allogeneic encapsulated cell-based gene therapy, is the first therapy to be approved for macular telangiectasia type 2. The FDA approved ...

While in high school, I finally took the initiative to find answers for my condition, and that's when my dermatologist told me about rosacea. Rosacea is a chronic skin condition characterized by ...

About Macular Telangiectasia Type 2 (MacTel) Macular Telangiectasia Type 2 (MacTel), or idiopathic macular telangiectasia type 2, is a bilateral, neurodegenerative disease in adults with ...

The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in adults in November 2024. Interested parties are invited to visit Journey Medical’s booth 2181 to learn about ...